# US 2014/0235724 A1 · Amide dendrimer compositions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0235724 A1
- Document ID: US20140235724A1
- Status: Published application
- Kind: A1
- Application number: 14/260,917
- Filed: 2014-04-24
- Published: 2014-08-21
- Earliest claimed: 2006-09-29
- Assignees: Genzyme Corporation
- Applicants: Genzyme Corporation
- Inventors: Pradeep K. DHAL; David J. HARRIS; Stephen Randall HOLMES-FARLEY; Chad C. HUVAL; Vitaly NIVOROZHKIN; Bruce SHUTTS
- Web page: https://patentgrep.com/patent/US20140235724A1

## CPC

- C08G 69/40: Polyamides containing oxygen in the form of ether groups (C08G69/12, C08G69/32 take precedence)
- A61K 31/785: Polymers containing nitrogen
- A61P 3/12: for electrolyte homeostasis
- A61P 3/14: for calcium homeostasis (vitamin D A61P3/02; parathyroid hormones A61P5/18; calcitonin A61P5/22; osteoporosis A61P19/10; bone metastasis A61P35/04)
- A61P 5/18: of the parathyroid hormones
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 13/12: of the kidneys
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 21/02: Muscle relaxants, e.g. for tetanus or cramps
- A61P 27/02: Ophthalmic agents
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07C 235/08: having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C 237/10: having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
- C08G 83/003: {Dendrimers}
- A61K 8/72: containing organic macromolecular compounds
- C08L 101/00: Compositions of unspecified macromolecular compounds
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

Amide compounds, amide polymers, compositions including amide compounds and amide polymers may be used to bind target ions, such as phosphorous-containing compounds in the gastrointestinal tract of animals. In some cases, amide compounds and amide polymers may include a core derived from an amide polyol and an organic polyacid or ester.

## Claims

### Claim at position 1

1-100. (canceled)

### Claim 101

A pharmaceutical composition comprising,
a) an amide compound represented by the following Formula III:
wherein
R3 is independently represented by the following Formula II:
wherein
p, q and r independently represent an integer from 0-2;
R4 independently represents
wherein
m independently represents an integer from 1-20;
R5 independently represents a hydrogen radical; a substituted or un-substituted alkyl radical; a substituted or un-substituted aryl radical; or R5 and a neighboring R5 together represent a link or links comprising a residue of a crosslinking agent, a substituted or un-substituted alicyclic radical, a substituted or un-substituted aromatic radical, or a substituted or un-substituted heterocyclic radical; or R5 represents a link with another compound;
b) a crosslinking agent or residue thereof; and
c) a pharmaceutically acceptable excipient.

### Claim 102

A pharmaceutical composition comprising
a) an amide compound represented by the following Formula V:
wherein
R3 is independently represented by the following Formula II:
wherein
p, q and r independently represent an integer from 0-2;
R4 independently represents
wherein
m independently represents an integer from 1-20;
R5 independently represents a hydrogen radical; a substituted or un-substituted alkyl radical; a substituted or un-substituted aryl radical; or R5 and a neighboring R5 together represent a link or links comprising a residue of a crosslinking agent, a substituted or un-substituted alicyclic radical, a substituted or un-substituted aromatic radical, or a substituted or un-substituted heterocyclic radical; or R5 represents a link with another compound;
b) a crosslinking agent or residue thereof; and
c) a pharmaceutically acceptable excipient.

### Claim 103

A pharmaceutical composition comprising
a) an amide compound represented by the following Formula VI:
b) crosslinking agent or residue thereof; and
c) a pharmaceutically acceptable excipient.
